{
    "nct_id": "NCT05258305",
    "official_title": "Prospective Study on Fat Retention When Using the AuraGen 1-2-3â„¢ With AuraClensâ„¢ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast",
    "inclusion_criteria": "* Female patients > 22 years and < 65 years of age.\n* Patients with a BMI < 35.\n* Patients undergoing an aesthetic fat grafting procedure to the breast (breast augmentation) with or without a breast implant.\n* Patients must be able to provide written informed consent, understand and be willing to comply with study-related procedures and follow-up visits.\n* Patients must be non-smokers.\n* Patients with available/adequate harvest sites for fat grafting.\n* Anticipated harvested fat volume between 200 and 700 cc.\n* Anticipated fat injection volume between 50 and 350 cc per breast.\n* Anticipated breast implant volume between 200 and 550 cc.\n* Patients must agree to maintain their weight (i.e., within 5%) by not making any major changes in diet or lifestyle during the study.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 22 Years\nMust have maximum age of 65 Years",
    "exclusion_criteria": "* Skin rash in the treatment area.\n* Patients who smoke or use nicotine products.\n* Patients with bleeding disorders or currently taking anticoagulants.\n* Patients with history of trauma or surgery to the treatment area.\n* Patients with history of breast cancer.\n* Active, chronic, or recurrent infection.\n* Compromised immune system.\n* Hypersensitivity to analgesic agents.\n* Co-morbid condition that could limit ability to participate in the study or to comply with follow-up requirements.\n* Untreated drug and/or alcohol abuse.\n* Pregnant or breastfeeding.\n* Any issue that, at the discretion of the Investigator, would contra-indicate the patient's participation.\n* Patients who do not wish to have the study area (breast) photographed.\n\nReconstruction Subjects\n\nInclusion Criteria:\n\n* Female patients > 18 years and < 65 years of age.\n* Patients with a BMI < 35.\n* Patients undergoing a fat grafting procedure to the breast in a second or third stage of a staged breast reconstruction, with or without a breast implant.\n* Patient is at least 1 year post-completion of chemotherapy.\n* Patients must be able to provide written informed consent, understand and be willing to comply with study-related procedures and follow-up visits.\n* Patients must be non-smokers.\n* Patients with available/adequate harvest sites for fat grafting.\n* Anticipated harvested fat volume between 200 and 700 cc.\n* Anticipated fat injection volume between 50 nd 350cc per breast.\n* Anticipated breast implant volume (if applicable) between 200 and 550 cc.\n* Patients must agree to maintain their weight (i.e., within 5%) by not making any major changes in diet or lifestyle during the study.\n\nExclusion Criteria:\n\n* Skin rash in the treatment area.\n* Patients who smoke or use nicotine products.\n* Patients with bleeding disorders or currently taking anticoagulants.\n* Patients undergoing active treatment for breast cancer.\n* Active, chronic, or recurrent infection.\n* Compromised immune system.\n* Hypersensitivity to analgesic agents.\n* Co-morbid condition that could limit ability to participate in the study or to comply with follow-up requirements.\n* Untreated drug and/or alcohol abuse.\n* Pregnant or breastfeeding.\n* Any issue that, at the discretion of the Investigator, would contra-indicate the patient's participation.\n* Patients who do not wish to have the study area (breast) photographed.",
    "miscellaneous_criteria": "Augmentation Subjects"
}